Preface

Filipe Palavra; Flávio Reis; Daniela Marado; Armando Sena

doi:10.1007/978-3-319-16018-4

Preface

Filipe Palavra, Flávio Reis, Daniela Marado, Armando Sena

Research output: Chapter in Book/Report/Conference proceeding › Foreword/postscript

4 Citations (Scopus)

Abstract

This book discusses recent advances in the area of cardiometabolic risk biomarkers of chronic inflammatory and cardiovascular disorders. Tackling the topic in a systematic manner, the book starts with an introduction to cardiometabolic risk and its clinical relevance, comparing emergent and classical biomarkers. It then goes on to discuss cardiometabolic risk biomarkers in a range of diseases, including diabetes, ischemic stroke and neurodegenerative disorders."Biomarkers of Cardiometabolic Risk, Inflammation and Disease"is aimed at doctors specializing in internal medicine, neurology, cardiology, rheumatology, nephrology or endocrinology and will also be of interest to GPs, trainee doctors and clinical and basic researchers working on cardiovascular and autoimmune disorders."

Original language	English
Title of host publication	Biomarkers of Cardiometabolic Risk, Inflammation and Disease
Publisher	Springer International Publishing
Pages	v-vi
ISBN (Electronic)	9783319160184
ISBN (Print)	9783319160177
DOIs	https://doi.org/10.1007/978-3-319-16018-4
Publication status	Published - 1 Jan 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/978-3-319-16018-4

Cite this

@inbook{41af8452de514948ab994051f161126c,

title = "Preface",

abstract = "This book discusses recent advances in the area of cardiometabolic risk biomarkers of chronic inflammatory and cardiovascular disorders. Tackling the topic in a systematic manner, the book starts with an introduction to cardiometabolic risk and its clinical relevance, comparing emergent and classical biomarkers. It then goes on to discuss cardiometabolic risk biomarkers in a range of diseases, including diabetes, ischemic stroke and neurodegenerative disorders.{"}Biomarkers of Cardiometabolic Risk, Inflammation and Disease{"}is aimed at doctors specializing in internal medicine, neurology, cardiology, rheumatology, nephrology or endocrinology and will also be of interest to GPs, trainee doctors and clinical and basic researchers working on cardiovascular and autoimmune disorders.{"}",

author = "Filipe Palavra and Fl{\'a}vio Reis and Daniela Marado and Armando Sena",

note = "Publisher Copyright: {\textcopyright} Springer International Publishing Switzerland 2015.",

year = "2015",

month = jan,

day = "1",

doi = "10.1007/978-3-319-16018-4",

language = "English",

isbn = "9783319160177",

pages = "v--vi",

booktitle = "Biomarkers of Cardiometabolic Risk, Inflammation and Disease",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Preface

AU - Palavra, Filipe

AU - Reis, Flávio

AU - Marado, Daniela

AU - Sena, Armando

PY - 2015/1/1

Y1 - 2015/1/1

N2 - This book discusses recent advances in the area of cardiometabolic risk biomarkers of chronic inflammatory and cardiovascular disorders. Tackling the topic in a systematic manner, the book starts with an introduction to cardiometabolic risk and its clinical relevance, comparing emergent and classical biomarkers. It then goes on to discuss cardiometabolic risk biomarkers in a range of diseases, including diabetes, ischemic stroke and neurodegenerative disorders."Biomarkers of Cardiometabolic Risk, Inflammation and Disease"is aimed at doctors specializing in internal medicine, neurology, cardiology, rheumatology, nephrology or endocrinology and will also be of interest to GPs, trainee doctors and clinical and basic researchers working on cardiovascular and autoimmune disorders."

AB - This book discusses recent advances in the area of cardiometabolic risk biomarkers of chronic inflammatory and cardiovascular disorders. Tackling the topic in a systematic manner, the book starts with an introduction to cardiometabolic risk and its clinical relevance, comparing emergent and classical biomarkers. It then goes on to discuss cardiometabolic risk biomarkers in a range of diseases, including diabetes, ischemic stroke and neurodegenerative disorders."Biomarkers of Cardiometabolic Risk, Inflammation and Disease"is aimed at doctors specializing in internal medicine, neurology, cardiology, rheumatology, nephrology or endocrinology and will also be of interest to GPs, trainee doctors and clinical and basic researchers working on cardiovascular and autoimmune disorders."

UR - http://www.scopus.com/inward/record.url?scp=84944097603&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-16018-4

DO - 10.1007/978-3-319-16018-4

M3 - Foreword/postscript

AN - SCOPUS:84944097603

SN - 9783319160177

SP - v-vi

BT - Biomarkers of Cardiometabolic Risk, Inflammation and Disease

PB - Springer International Publishing

ER -

Preface

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this